Results 11 to 20 of about 106,528 (297)
Efficacy of Adalimumab for Nail Psoriasis During 24 Months of Continuous Therapy
Acta Dermato-Venereologica, 2020 Psoriatic nail symptoms are frequent in psoriasis, affecting up to 80% of patients. Therapy responses to nail symptoms are often limited. In this multicentre non-interventional prospective study, 267 patients with nail involvement were treated with ...
Georgios Kokolakis +4 more
doaj +1 more source
Recent advances in phototherapy for psoriasis [version 1; referees: 2 approved]
F1000Research, 2016 Phototherapy involves repeated exposure of the skin to ultraviolet light to treat various inflammatory skin conditions such as psoriasis. Recent studies have identified specific immunologic effects of phototherapy that may underlie phototherapy efficacy.
Mio Nakamura +2 more
doaj +1 more source
Journal of the Egyptian Women’s Dermatologic Society, 2020 Background Methotrexate and phototherapy are traditional treatments for psoriasis, but their prolonged use is associated with cumulative toxicity, so physicians are in a continuous need for tools to predict and monitor the progress of the disease ...
Shaimaa I Omar, Eman M Hassan
doaj +1 more source
Erythrodermic Psoriasis Managed with Risankizumab
Case Reports in Dermatology, 2022 Erythrodermic psoriasis (EP) is a severe, often refractory, variant of psoriasis. Due to the high morbidity and mortality rate associated with EP and other causes of erythroderma, they are often classified as dermatologic emergencies.
Abdulmajeed Alajlan +4 more
doaj +1 more source
Psoriasis comorbidity: prevalence, diagnosis and treatment [PDF]
Zhenduanxue lilun yu shijian, 2023 The global incidence of psoriasis is about 1%-3%, and in China is about 0.47%. It is reported that 57.9% of psoriasis patients have at least one psoriasis comorbidity, which not only affects the progression and severity of psoriasis, but also affects the
SHI Yuling, CHEN Wenjuan
doaj +1 more source
From pathogenesis to current treatment of the cutaneous psoriasis - a literature review
Journal of Education, Health and Sport, 2023 Introduction: Psoriasis is a chronic inflammatory autoimmune disease that can be divided into several subtypes based on the areas of the body occupied by the lesions and the severity of the disease.
Wiktoria Jakubowska +7 more
doaj +1 more source
Dermatology Reports, 2023 Genital psoriasis affects 33-63% patients with psoriasis during the course of disease, usually leading to a severe reduction of patient’s quality of life.
Andrea Cortese +8 more
doaj +1 more source
Psoriasis Pathogenesis and Treatment [PDF]
International Journal of Molecular Sciences, 2019 Research on psoriasis pathogenesis has largely increased knowledge on skin biology in general. In the past 15 years, breakthroughs in the understanding of the pathogenesis of psoriasis have been translated into targeted and highly effective therapies providing fundamental insights into the pathogenesis of chronic inflammatory diseases with a dominant ...
Rendon, Adriana, Schäkel, Knut
openaire +2 more sources
Psoriatic Arthritis during Treatment with Bevacizumab for Anaplastic Oligodendroglioma
Case Reports in Rheumatology, 2012 Bevacizumab is a recombinant humanised monoclonal antibody directed against the vascular endothelial growth factor (VEGF). The drug, alone or in combination with other anticancer agents, has been shown to be effective against several types of neoplasms ...
D. Graceffa +6 more
doaj +1 more source
The Safety of Systemic Treatments That Can Be Used for Geriatric Psoriasis Patients: A Review
Dermatology Research and Practice, 2012 Background. Patients with moderate-to-severe psoriasis are often treated with systemic immunosuppressant agents that decrease immune system function. For the elderly, these medications are often problematic due to their already immunosuppressed state and
Jillian W. Wong, John Y. M. Koo
doaj +1 more source